A combination of chemotherapy and chimeric antigen receptor (CAR) T cells designed to target the protein HER2 was found to be safe in patients with advanced HER2-positive sarcoma.
from Medindia Health News https://ift.tt/2TKBfHT
LATEST HEALTH NEWS
Reviewed by MZ Digital Marketing Agency
on
April 01, 2019
Rating: 5
No comments
Thanks for comment via will connect you within 24 hours.
No comments
Thanks for comment via will connect you within 24 hours.